Atlas FDA

DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M

FDA 510(k) clearance K031177 · decided 2003-06-19

Clearance details

K-number
K031177
Device name
DIASTAT ANTI-B2 GLYCOPROTEIN 1 IGM, MODEL FBGP 100M
Applicant
Axis-Shield Diagnostics, Ltd.
Decision
Substantially Equivalent
Date received
2003-04-14
Decision date
2003-06-19
Days to decision
66 days
Clearance type
Traditional
Product code
MSV
Device class
2
Regulation number
866.5660
Medical specialty
Immunology
Advisory committee
Immunology
Location
Dundee, GB
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Axis-Shield Diagnostics

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
Aptiva APS IgA Reagent (K243979)Inova Diagnostics, Inc.2026-02-06
EliA B2-Glycoprotein I IgA Immunoassay, EliA Cardiolipin IgA Immunoassay (K181329)Phadia AB2018-06-25
ImmuLisa Enhanced B2GP1 IgA Antibody ELISA, ImmuLisa Enhanced B2GP1 IgG Antibody ELISA, ImmuLisa Enhanced B2GP1 IgM Antibody ELISA, ImmuLisa Enhanced B2GP1 IgA/IgG/IgM Antibody ELISA (K162788)Immco Diagnostics, Inc.2017-06-19
QUANTA Flash B2GP1-Domain1, QUANTA Flash B2GP1-Domain1 Controls, HemosIL AcuStar Anti-B2GPI Domain 1, HemosIL AcuStar Anti-B2GPI Domain 1 Controls (K152875)Inova Diagnostics, Inc.2015-12-21
QUANTA FLASH ¿2GP1-DOMAIN1; CONTROLS, HEMOSIL ACUSTAR ANTI-¿2GPI DOMAIN1; CONTROLS. (K141274)Inova Diagnostics, Inc.2015-02-13
ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAY (K112414)Phadia US, Inc.2012-06-22
HEMOSIL ACUSTAR ANTI-B2 GLYCOPROTEIN-I; IGG, IGM, IGG CONTROLS, IGM CONTROLS (K091556)Instrumentation Laboratory CO2010-05-21
THERATEST EL-BETA2GPI (IGM-IGG-IGA), THERATEST EL--BETA2GPI SCR (K092757)Thera-Test Laboratories, Inc.2009-10-09
IGG ANTI-ATHEROX TEST KIT (K072032)Corgenix, Inc.2008-04-04
AESKULSKA BETA2-GLYCO-A (K062217)Aesku, Inc.2006-12-13
VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896 (K040451)Pharmacia Deutschland GmbH2004-05-11
VARELISA B2 GLYCOPROTEIN I IGG ANTIBODIES, MODELS 18748 AND 18796 (K040449)Pharmacia Deutschland GmbH2004-05-11

Recalls involving this device

No recalls on record reference this clearance.